C2C Wealth Management’s Eli Lilly LLY Stock Holding History

C2C Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$948K	Hold	790	–	–	0.74%	34
2026 Q1	$727K	Hold	790	–	–	0.61%	39
2025 Q4	$849K	Hold	790	–	–	0.72%	35
2025 Q3	$603K	Hold	790	–	–	0.52%	44
2025 Q2	$616K	Hold	790	–	–	0.56%	43
2025 Q1	$652K	Hold	790	–	–	0.61%	39
2024 Q4	$610K	Hold	790	–	–	0.57%	41
2024 Q3	$655K	Hold	790	–	–	0.61%	39
2024 Q2	$715K	Hold	790	–	–	0.7%	34
2024 Q1	$615K	Sell	790 -90	-10%	-$64K	0.61%	38
2023 Q4	$511K	Sell	880 -10,301	-92%	-$6.01M	0.43%	54
2023 Q3	$5.93M	Hold	11,181	–	–	0.84%	10
2023 Q2	$5M	Sell	11,181 -250	-2%	-$105K	0.66%	11
2023 Q1	$4.22M	Sell	11,431 -84	-0.7%	-$28.3K	0.68%	13
2022 Q4	$4.05M	Hold	11,515	–	–	0.7%	11
2022 Q3	$3.8M	Hold	11,515	–	–	0.74%	15
2022 Q2	$3.76M	Hold	11,515	–	–	0.69%	15
2022 Q1	$3.42M	Hold	11,515	–	–	0.58%	17
2021 Q4	$3.18M	Buy	+11,515	New	+$2.92M	0.46%	25

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

C2C Wealth Management's LLY Position: Q2 2026 in Review

C2C Wealth Management held its Eli Lilly (LLY) position steady in Q2 2026 at 790 shares worth $948K. The position accounts for 0.74% of the portfolio, ranked #34.

C2C Wealth Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.93M in Q3 2023. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

C2C Wealth Management held 790 shares of Eli Lilly worth $948K as of Q2 2026.
C2C Wealth Management left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.74% of C2C Wealth Management's portfolio in Q2 2026, its #34 holding.
C2C Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
C2C Wealth Management's Eli Lilly position peaked at $5.93M in Q3 2023.
2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on C2C Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.